Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

rocuronium bromide, Quantity: 10 g/L

Verfügbar ab:

Fresenius Kabi Australia Pty Ltd

INN (Internationale Bezeichnung):

Rocuronium bromide

Darreichungsform:

Injection, solution

Zusammensetzung:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Verabreichungsweg:

Intravenous

Einheiten im Paket:

10 x 5mL, 5 x 5mL

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Produktbesonderheiten:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2014-11-12